» Articles » PMID: 31216636

Characterizing Eckol As a Therapeutic Aid: A Systematic Review

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2019 Jun 21
PMID 31216636
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The marine biosphere is a treasure trove of natural bioactive secondary metabolites and the richest source of structurally diverse and unique compounds, such as phlorotannins and halo-compounds, with high therapeutic potential. Eckol is a precursor compound representing the dibenzo-1,4-dioxin class of phlorotannins abundant in the species, which are marine brown algae having a ubiquitous distribution. In search of compounds having biological activity from macro algae during the past three decades, this particular compound has attracted massive attention for its multiple therapeutic properties and health benefits. Although several varieties of marine algae, seaweed, and phlorotannins have already been well scrutinized, eckol deserves a place of its own because of the therapeutic properties it possesses. The relevant information about this particular compound has not yet been collected in one place; therefore, this review focuses on its biological applications, including its potential health benefits and possible applications to restrain diseases leading to good health. The facts compiled in this review could contribute to novel insights into the functions of eckol and potentially enable its use in different uninvestigated fields.

Citing Articles

Extract Ameliorates Colitis in In Vitro and In Vivo Models Through Modulation of mTOR Axis and Gut Microbiota Composition.

Wang Q, Im Y, Park J, Lee H, Ryu D, Kim H Foods. 2025; 14(5).

PMID: 40077417 PMC: 11899094. DOI: 10.3390/foods14050714.


Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?.

Repici A, Hasan A, Capra A, Scuderi S, Paterniti I, Campolo M Mar Drugs. 2024; 22(8).

PMID: 39195452 PMC: 11355360. DOI: 10.3390/md22080336.


In Vitro and In Vivo Antidiabetic, α-Glucosidase Inhibition and Antibacterial Activities of Three Brown Algae, , , and , and a Red Alga, from the Persian Gulf.

Moheimanian N, Mirkhani H, Purkhosrow A, Sohrabipour J, Jassbi A Iran J Pharm Res. 2023; 22(1):e133731.

PMID: 38116547 PMC: 10728852. DOI: 10.5812/ijpr-133731.


Marine Resources Offer New Compounds and Strategies for the Treatment of Skin and Soft Tissue Infections.

Labes A Mar Drugs. 2023; 21(7).

PMID: 37504918 PMC: 10381745. DOI: 10.3390/md21070387.


Anti‑tumor effects of an aqueous extract of in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells.

Gong J, Kim J, Park S, Lee S, Choi Y, Choi S Oncol Rep. 2023; 49(6).

PMID: 37165874 PMC: 10196738. DOI: 10.3892/or.2023.8565.


References
1.
Eom S, Lee M, Lee E, Kim Y, Kim T . Pancreatic lipase inhibitory activity of phlorotannins isolated from Eisenia bicyclis. Phytother Res. 2012; 27(1):148-51. DOI: 10.1002/ptr.4694. View

2.
Chen J, Lim J, Sohn E, Choi Y, Han E . Growth-inhibitory effect of a fucoidan from brown seaweed Undaria pinnatifida on Plasmodium parasites. Parasitol Res. 2008; 104(2):245-50. DOI: 10.1007/s00436-008-1182-2. View

3.
Hauser A, Attwood M, Rask-Andersen M, Schioth H, Gloriam D . Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017; 16(12):829-842. PMC: 6882681. DOI: 10.1038/nrd.2017.178. View

4.
Rengasamy K, Aderogba M, Amoo S, Stirk W, van Staden J . Potential antiradical and alpha-glucosidase inhibitors from Ecklonia maxima (Osbeck) Papenfuss. Food Chem. 2013; 141(2):1412-5. DOI: 10.1016/j.foodchem.2013.04.019. View

5.
Wijesinghe W, Ko S, Jeon Y . Effect of phlorotannins isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibitory activity. Nutr Res Pract. 2011; 5(2):93-100. PMC: 3085808. DOI: 10.4162/nrp.2011.5.2.93. View